Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Relapsed Acute Promyelocytic Leukemia With Arsenic Trioxide (Phase IV Study)

NCT00196768 is registered in ClinicalTrials.gov with German AML Cooperative Group as lead sponsor.

NCT NCT00196768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00196768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Relapsed Acute Promyelocytic Leukemia With Arsenic Trioxide (Phase IV Study)
Lead sponsor
German AML Cooperative Group
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2005
Completion date
December 31, 2010
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory acute promyelocytic leukemia, relapsed acute promyelocytic leukemia